Clinical Trial Update: Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the combination of autologous mesenchymal stem cells (MSC) and hematopoietic stem cells (HSC) infusion in patients with decompensated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis Liver

Drugs mentioned

• Autologous mesenchymal stem cells (mesenchymal stem cells)
• Hematopoietic stem cells (hematopoietic stem cells)

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: Cirrhosis, Liver | Phase 4 | Status: COMPLETED